Maintenance oral corticosteroids for severe eosinophilic asthma - RB&HH Education Skip to the content
Log in Register
Login
  • Events
  • Expert talks
    • Grand rounds
  • Courses
  • Clinical training
    • Clinical training
    • Clinical fellowships
    • Clinical observerships
    • Other training opportunities
  • About us
    • About us
    • Our specialists
    • News
    • FAQs
  • Events
  • Expert talks
    • Grand rounds
  • Courses
  • Clinical training
    • Clinical training
    • Clinical fellowships
    • Clinical observerships
    • Other training opportunities
  • About us
    • About us
    • Our specialists
    • News
    • FAQs
  • LOG IN
  • REGISTER
  • Login

Maintenance oral corticosteroids for severe eosinophilic asthma

Maintenance oral corticosteroids for severe eosinophilic asthma
Professor Andrew Menzies-Gow
45 minutes
Maintenance oral corticosteroids for severe eosinophilic asthma 1 Topic
Module Content
0% Complete 0/1 Steps
not-completed
Maintenance oral corticosteroids for severe eosinophilic asthma
Watch the Expert Talk by clicking the link above.
Access talk FREE

Curated for

Secondary care doctors & Tertiary care doctors

Subject

Respiratory medicine

Duration

45 minutes

Certified:

CPD
EXPERT TALK
Overview

Asthma is the most common chronic respiratory condition in the world.

Professor Andrew Menzies-Gow discusses the current European Medicines Agency (EMA) approved biological treatments for severe asthma and the current evidence for OCS use in asthma. The talk overviews the PONENTE Study, an open-label, single-arm study that included nearly 600 adults with severe, eosinophilic asthmas receiving benralizumab.

CONTENT
Learning objectives
  • Discuss why we need to change the paradigm of OCS use in asthma
  • Discuss OCS-sparing effects of omalizumab, mepolizumab, reslizumab, dupliumab
  • PONENTE study; its design and inclusion criteria and why it is important in terms of changing our clinical practice
EXPERT
Professor Andrew Menzies-Gow

Professor Andrew Menzies-Gow is a consultant in respiratory medicine with a particular interest in patients with severe asthma or asthma that is difficult to control.

Learn more about Professor Andrew Menzies-Gow, his research interests and teaching here.

Would you like to know more?

Please get in touch with our team who will be able to assist you.

Contact us
Register
  • Events
  • Expert talks
  • Courses
  • About us
  • FAQs
  • Privacy Policy
  • Terms and Conditions
  • Cookies Policy
  • Contact us
  • Guy’s and St Thomas’ Specialist Care
  • Royal Brompton & Harefield Hospitals
  • Royal Brompton & Harefield Hospitals Alumni Network
Register

To the top ↑ Up ↑

© 2025 Guy's and St Thomas' NHS Foundation Trust

Twitter LinkedIn
Log In
Accessing this course requires a login. Please enter your credentials below!

Forgotten your password?
Register
Don't have an account? You can register for one.
Register for an account

Registration confirmation will be emailed to you.